Nader Hanna
Biographic Data
| ID | 5537508 |
|---|---|
| NAME | Nader Hanna |
| GIVEN NAMES | Nader |
| FAMILY NAME | Hanna |
| SIGNATURE | HANNA N |
| AFFILIATIONS | University of Maryland, Baltimore |
| ORCID | 0000-0001-5755-5910 |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2009 |
| LATEST PUBLICATION YEAR | 2015 |
| H-INDEX | 0 |
Algorithm for Identifying Chemotherapy/Biological Regimens for Metastatic Colon Cancer in Seer-Medicare
BACKGROUND: Metastatic colon cancer (mCC) patients often receive multiple lines of chemotherapy/biological treatment (TX), yet subsequent TX lines have not been sufficiently examined using SEER-Medicare data. We developed an algorithm that identifies the number and type of TX lines received by mCC patients. METHODS: The algorithm rules for detecting TX lines were developed a priori and applied to SEER-Medicare data for 7951 elderly mCC patients, …
Trends in Disparities in Receipt of Adjuvant Therapy for Elderly Stage III Colon Cancer Patients
BACKGROUND: Race disparities in adjuvant chemotherapy for stage III colon cancer patients have been documented, and medical oncologist evaluation is a critical step in the treatment process. Recent healthcare system and environmental changes may have reduced treatment gaps. OBJECTIVES: To examine differential rates of oncologist evaluation and conditional treatment, by race, and to determine whether changing evaluation and treatment patterns redu…
No prominent works on this page.
Trends in Disparities in Receipt of Adjuvant Therapy for Elderly Stage III Colon Cancer Patients
BACKGROUND: Race disparities in adjuvant chemotherapy for stage III colon cancer patients have been documented, and medical oncologist evaluation is a critical step in the treatment process. Recent healthcare system and environmental changes may have reduced treatment gaps. OBJECTIVES: To examine differential rates of oncologist evaluation and conditional treatment, by race, and to determine whether changing evaluation and treatment patterns redu…
Algorithm for Identifying Chemotherapy/Biological Regimens for Metastatic Colon Cancer in Seer-Medicare
BACKGROUND: Metastatic colon cancer (mCC) patients often receive multiple lines of chemotherapy/biological treatment (TX), yet subsequent TX lines have not been sufficiently examined using SEER-Medicare data. We developed an algorithm that identifies the number and type of TX lines received by mCC patients. METHODS: The algorithm rules for detecting TX lines were developed a priori and applied to SEER-Medicare data for 7951 elderly mCC patients, …
Cancer (2 works) · Colorectal cancer (2 works) · Colorectal Cancer Surgical Treatments (2 works) · Internal Medicine (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Oncology (2 works) · Oncology (2 works) · Adjuvant (1 work) · Adjuvant therapy (1 work)